The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Abstract
OBJECTIVE: The nature of the independent relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes remains unclear. Few studies have aimed to clarify this relationship independent of obesity in longitudinal population-based cohorts. RESEARCH DESIGN AND METHODS: We used the Australian Longitudinal Study on Women’s Health (ALSWH) (2000–2015) database to estimate nationwide incidence rates and predictors of type 2 diabetes among women aged 18–42 using person-time and survival analysis. RESULTS: Over a follow-up of 1,919 person-years (PYs), 186 women developed type 2 diabetes. The incidence rate was 4.19/1,000 PYs and 1.02/1,000 PYs (P < 0.001) in PCOS and control subjects. On subgroup analyses across healthy-weight, overweight, and obese categories of women, the incidence rates for type 2 diabetes were 3.21, 4.67, and 8.80, whereas incidence rate ratios were 4.68, 3.52, and 2.36 (P < 0.005) in PCOS versus age-matched control subjects. PCOS was one of the most influential predictors for type 2 diabetes in the entire cohort (hazard ratio 3.23, 95% CI 2.07–5.05, P < 0.001) adjusting for BMI, education, area of residence, and family history of type 2 diabetes. CONCLUSIONS: Women with PCOS are at an increased risk of type 2 diabetes, irrespective of age and BMI. The incidence of type 2 diabetes increases substantially with increasing obesity; yet, PCOS adds a greater relative risk in lean women. Based on the overall moderate absolute clinical risk demonstrated here, guideline recommendations suggest type 2 diabetes screening every 1–3 years in all women with PCOS, across BMI categories and age ranges, with frequency influenced by additional type 2 diabetes risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 1×
“Previous studies have been inconclusive about the independent effect of PCOS on type 2 diabetes, with methodological limitations including small sample sizes (8,9,11), use of”
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Self-citation
Research works printed but not linked: 1
- Polycystic Australian Alliance, 2011, Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Cited by
Items 101–165 of 165
Yin, S., Zhu, F., Zhou, Q., Chen, M., Wang, X., & Chen, Q. (2024) · Phytotherapy Research · doi:10.1002/ptr.8362 · Cited by 5
“Participants include healthy, overweight, and obese individuals, as well as patients with diseases such as NAFLD, T2DM, PCOS, metabolic syndrome (MS), and hyperlipidemia.”
InfluentialGu, H., Li, L., Zhou, B., Li, M., Zhong, W., Wei, X., & Zhong, X. (2022) · Technology and Health Care · doi:10.3233/thc-228007 · Cited by 4
Acosta‐Martínez, M. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_666 · Cited by 6
Cree‐Green, M. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.09.004 · Cited by 6
“Finally, regardless of BMI, women with PCOS have increased rates of dysglycemia, including gestational diabetes, pre-diabetes and type 2 diabetes (11, 12).”
BackgroundStener‐Victorin, E., Eriksson, G., Shrestha, M. M., Paris, V. R., Lu, H., Banks, J. L., Samad, M., Perian, C., Jude, B., Engman, V., et al. (2023) · medRxiv · doi:10.1101/2023.03.08.23286896 · Cited by 3
“More than 50% of women with PCOS are overweight or obese, and obesity worsens all symptoms, including insulin resistance (Kakoly et al. , 2019; Barber & Franks, 2021).”
Liu, K., Jiao, R., Ji, J., Yao, W., Han, C.-R., Zhao, X., & Zhao, J. (2025) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2025.04.007 · Cited by 4
da Silva, J. V. M. B., Delgado, J. C. S., Couto, N. M. D. S., Hortúa, A. M. J., Ribeiro, V. B., de Melo, K. Y., Ferreira, L. D., de Macedo, A. B. O. D., & de Souza, H. C. D. (2025) · Clinical Endocrinology · doi:10.1111/cen.70042 · Cited by 3
Çelik, Z. M., Kurnaz, D., Özcan, A., Keskin, E., Unlugedik, E., & Aktaç, Ş. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70307 · Cited by 7
Metabolic Implications of PCOS
Naveed, A., Shah, R., Bernier, A., Muradova, V., Gurol, E. S., Cree‐Green, M., & Whooten, R. (2025) · Current Pediatrics Reports · doi:10.1007/s40124-025-00364-8 · Cited by 3
Khalafi, M., Fatolahi, S., Rahmatpanah, G., Symonds, M. E., Rosenkranz, S. K., Dinizadeh, F., & Batrakoulis, A. (2026) · BMC Women s Health · doi:10.1186/s12905-025-04240-x · Cited by 2
“Whilst ample evidence indicate that exercise enhances insulin sensitivity in individuals with diabetes and obesity [14, 60], conditions that are frequently observed along with PCOS [61], only a small number of studies show modest reductions in HOMA-IR among women with PCOS [39].”
Todorović, J., Dugalić, S., Şengül, D., Stanisavljevic, D. M., Detanac, D. A., Şengül, İ., Veiga, E. C. D. A., Terzić-Šupić, Z., Đurić, B., & Gojnić-Dugalić, M. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20221371 · Cited by 2
Warchala, A., Madej, P., Kochanowicz, M., & Krzystanek, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082227 · Cited by 1
“This is reflected in the fact that PCOS remains the most common endocrine disease of women of reproductive age [3], the most common cause of anovulatory infertility [4], and a substantial contributor to an early onset of type 2 diabetes [5], as well as psychological disorders [6].”
BackgroundChannabasamma, Siri, D., Harshitha, M., Babu, K. S., Mohammad, A., & Alkhayyat, A. (2024) · Odisha International Conference on Electrical Power Engineering, Communication and Computing Technology (ODICON) · doi:10.1109/odicon62106.2024.10797505 · Cited by 3
Tobias, J. J. T., & Japiassu, R. B. (2024) · REVISTA CIENTÍFICA ACERTTE · doi:10.63026/acertte.v4i4.181 · Cited by 2
Overview of the Comorbidity Between Medical Illnesses and Overweight/Obesity
Nolan, C. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-32545-9_4 · Cited by 2
Pouraghajan, K., & Mohamadpour, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3402313/v1 · Cited by 3
Shafqat, S., Anwar, Z., Rasool, R. U., Javaid, Q., & Ahmad, H. F. (2024) · Qeios · doi:10.32388/67kz7s.3 · Cited by 2
Santos, M. P., Azevedo‐Martins, A. K., Rodrigues, A. O., Aquino, N. S. S., & Evangelista, F. S. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.97 · Cited by 3
Ronald, C. W., Chow, E. W., Ng, N. Y. H., Sugiyama, T., Deng, Y., Tam, W. H., Lau, S., Poon, L. C., Zhang, C., & Sriram, U. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70095 · Cited by 3
“Multiple longitudinal studies and meta-analyses have con fi rmed a higher risk of incident T2DM or progression of diabetes in women with PCOS 37, 42 – 45 .”
Pharmacotherapeutic Role of Ketohexokinase in Metabolic Disorders and PCOS: A Systematic Review
Srivastava, A. K., Saxena, G., Mahawar, N., Chhabra, B., & Chitme, H. R. (2025) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-025-01976-3 · Cited by 2
“Additionally, because type 2 diabetes (T2D) is frequently linked to obesity and insulin resistance, it is highly likely that a diabetic patient would have PCOS, which is frequently linked to pancreatic β-cell malfunction [102, 103].”
Chaudhary, V., Haloi, P., Munjal, K., & Chitme, H. R. (2025) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2025.2554517 · Cited by 4
“This suggests that women with PCOS are nearly 5 times more susceptible to developing type 2 diabetes [25].”
Tambde, R. C., Muntean, C., & Yaqoob, A. (2025) · 2025 International Conference on Artificial Intelligence, Computer, Data Sciences and Applications (ACDSA) · doi:10.1109/acdsa65407.2025.11166608 · Cited by 1
“This leads to issues like infertility, weight gain, acne, and excessive hair growth [1].”
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00010-3 · Cited by 2
杨, 宇. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1391943 · Cited by 1
The Role of ADAM17 in PCOS Pathogenesis: A review Paper
Preap, B., Hong, K., Chen, J., & Chen, J. (2024) · Journal of Health Science and Medical Therapy · doi:10.59653/jhsmt.v2i02.632 · Cited by 1
Nutritional Management of Polycystic Ovary Syndrome: Insights into Diet and Nutrition Strategies
Jan, B., Ahmad, S., Ibrahim, M., & Choudhary, B. (2024) · Natural Resources for Human Health · doi:10.53365/nrfhh/183616 · Cited by 2
“This data implies that women with PCOS are at a fivefold higher risk of developing T2DM compared to those without the condition (Kakoly et al., 2019), (Glintborg et al., 2015).”
BackgroundPolycystic Ovarian Syndrome: Current Insights
Naidu, S. J. K., Ramdin, S., Naicker, T., Moodley, J., Naidoo, G., & Govender, N. (2024) · Biomedical visualization · doi:10.1007/978-3-031-68501-9_8 · Cited by 2
Zhong, Y., Lai, D., Chen, Y., Luo, X., Lu, W., Shang, Y.-N., Zhang, L., & Zhou, H. (2019) · Medicine · doi:10.1097/md.0000000000017562 · Cited by 2
Connecting Obesity and Reproductive Disorders
Ahima, R. S., & Dias, J. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_54 · Cited by 3
Type I fiber decrease and ectopic fat accumulation in skeletal muscle from women with PCOSPreprint
Stener‐Victorin, E., Eriksson, G., Shrestha, M. M., Paris, V. R., Lu, H., Banks, J. L., Samad, M., Perian, C., Jude, B., Engman, V., et al. (2023) · eLife · doi:10.7554/elife.87592.2 · Cited by 1
Polycystic Ovarian Syndrome and Diabetes Mellitus: What's New?
Nasr, M. Y., Alhuqayl, T. A., Alshammari, H. A., Alkhudhayri, H., Alzin, M. B., & Sulimani, R. A. (2021) · Journal of Nature and Science of Medicine · doi:10.4103/jnsm.jnsm_140_20
Zhu, M., Xu, Y., Li, C., Lu, Z., Bi, K., Wang, K., Guo, P., Jiang, H., & Cao, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-693311/v1
Leonel, C. F. S., Lima, L. E. R., Campos, L. S., Wastowski, I. J., Souza, C. D. S. M., & Byk, J. (2022) · Research Society and Development · doi:10.33448/rsd-v11i17.39185 · Cited by 1
Cardiovascular risk reduction in polycystic ovary syndrome
Shams, P., Ahmed, I., & Samad, Z. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00027-x
Rocha, T. P. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-26042023-163620
Type I fiber decrease and ectopic fat accumulation in skeletal muscle from women with PCOSPreprint
Stener‐Victorin, E., Eriksson, G., Shrestha, M. M., Perian, C., Jude, B., Engman, V., Boi, R., Nilsson, E., Ling, C., Nyström, J., et al. (2023) · eLife · doi:10.7554/elife.87592.1 · Cited by 1
Shafqat, S., Anwar, Z., Rasool, R. U., Javaid, Q., & Ahmad, H. F. (2023) · Qeios · doi:10.32388/67kz7s
Polycystic Ovary Syndrome in Pediatric Obesity
Pereira-Eshraghi, C., Al-Rayess, H., Bomberg, E. M., & Cree‐Green, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-37380-0_11
Connecting Obesity and Reproductive Disorders
Ahima, R. S., & Dias, J. P. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_54-1
Connecting Obesity and Reproductive Disorders
Ahima, R. S., & Dias, J. P. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_54-2
Glintborg, D., Ollila, M., Møller, J. K., Pesonen, P., Persson, S., Elenis, E., Rubin, K. H., Gissler, M., Andersen, M., Poromaa, I. S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4673244
EFEITO DA ACUPUNTURA E FITOTERAPIA NO TRATAMENTO DA OBESIDADE EM ADULTOS: UMA REVISÃO SISTEMÁTICA
Leonel, C. F. S., Lima, L. E. R., Campos, L. S., Wastowski, I. J., Souza, C. D. S. M., & Byk, J. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n1-123
Lin, R., Wang, J., Fu, W., Tuo, S., Ran, J., Shao, Y., & Shao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3878317/v1
Cardiometabolic Complications of PCOS
Joham, A. E. (2023) · Fertility & Reproduction · doi:10.1142/s2661318223740067
Self-citationMacchione, R. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2023.tde-08082023-143833
Salman, O. A., & Sarhat, E. R. (2024) · South Asian Research Journal of Pharmaceutical Sciences · doi:10.36346/sarjps.2024.v06i03.005
Übersicht über die Komorbidität zwischen medizinischen Erkrankungen und Übergewicht/Fettleibigkeit
Nolan, C. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-55637-1_4
Evaluation of Sleep Disturbances in Women with Polycystic Ovary Syndrome
Krishnan, N., Suganya., B., & Hemamalini, A. J. (2024) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1341 · Cited by 2
Turemka, M., Mandziuk, A., Cygnarowicz, A., Wojtas, A. K., Zabojska, K., Korotko, U., Witowska, K., Biskupski, M., Hosseinnejad, N., & Sacher, K. (2024) · Quality in Sport · doi:10.12775/qs.2024.36.56601 · Cited by 1
Zhu, S., Zhu, M., & Zhang, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-5978075/v1
Research Progress of Comorbidity of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis
张, 欣. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153652
Wang, T., Qi, Z., Zhao, S., & Lian, F. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s509619
Polyzystisches Ovarsyndrom als geschlechtsspezifisches kardiometabolisches Risiko
Lee-Barkey, Y. H., Stratmann, B., Opacic, T., Klose, J. M., & Reger-Tan, S. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01349-3
Dietary acid load and risk of polycystic ovary syndrome: a case–control study
Karimi, M., Eslamian, G., Keshavarz, S. A., & Naghashzadeh, M. (2025) · Nutrire · doi:10.1186/s41110-025-00367-x
“This metabolic dysfunction contributes substantially to”
Martin, M., Rema, L. P., George, N., Francis, R., Gilvaz, S., Francis, J., Divya, P. J., Varghese, P. R., & Kumar, R. S. (2025) · Gene · doi:10.1016/j.gene.2025.149806
Polyzystisches Ovarsyndrom: Sinnvolle Betreuung über die Gynäkologie hinaus
Lee-Barkey, Y. H., Stratmann, B., Klose, J. M., & Reger-Tan, S. (2025) · Deutsches Ärzteblatt · doi:10.3238/persgyn.2025.10.17.05
Feng, T., Wang, Q. L., Shen, F., & Yang, J. (2025) · International Journal of Endocrinology · doi:10.1155/ije/8861740 · Cited by 1
Ahmed, F., Alharbi, S. K., Alayed, R. A., & Althwieb, M. A. (2025) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.13.3.8
Azarbayjani, K., Sadatmahalleh, S. J., Mottaghi, A., & Nasiri, M. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01205-z · Cited by 2
“PCOS affects women of childbearing age, with an overall prevalence rate of 8–13% [3].”
Risk of Cardiovascular Disease among Women with PCOS
Chopra, A., & Bhattacharya, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010013
王, 月. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162501
Das polyzystische Ovarsyndrom (PCOS) – mehr als Insulinresistenz und Androgene
Reger-Tan, S., Lee-Barkey, Y. H., Klose, J. M., & Stratmann, B. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2595-2031
Madhu, S. V. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_709_26
“[14,15] In the current issue, Bauddh et al . have assessed glycaemic variability using a continuous glucose monitoring system (CGMS) in 50 non‑diabetic Indian women with PCOS.”
Martini, A., & Adler, J. (2026) · Trillium Diagnostik · doi:10.47184/td.2026.03.07
Das polyendokrine metabolische Ovarialsyndrom (PMOS) – mehr als Insulinresistenz und Androgene
Reger-Tan, S., Lee-Barkey, Y. H., Klose, J. M., & Stratmann, B. (2026) · Aktuelle Ernährungsmedizin · doi:10.1055/a-2929-4250
“1 ) [13].”
Metadata
- Authors
- Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E.
- Affiliations
- Monash University (AU)
- Monash Health (AU)
- Corresponding author
- Joham, Anju E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-01-31
- Volume
- 42
- Issue
- 4
- Pages
- 560-567
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2911538911
- Cited by
- 174
- References
- 32
- Citations by year
- 2026: 11 · 2025: 31 · 2024: 26 · 2023: 36 · 2022: 18 · 2021: 32 · 2020: 13 · 2019: 7
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, obesity, diabetes incidence, lean women, body mass index, diabetes screening, women's health, risk factors
- MeSH terms
- Adolescent, Adult, Australia, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Longitudinal Studies, Obesity, Polycystic Ovary Syndrome, Risk, Cohort Studies, Body Mass Index, Incidence, Overweight, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.